Aimed Bio Inc. (KOSDAQ:0009K0)

Aimed Bio Statistics

Total Valuation

Aimed Bio has a market cap or net worth of KRW 3.97 trillion. The enterprise value is 3.89 trillion.

Market Cap	3.97T
Enterprise Value	3.89T

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Aimed Bio has 64.16 million shares outstanding. The number of shares has increased by 18.19% in one year.

Current Share Class	64.16M
Shares Outstanding	64.16M
Shares Change (YoY)	+18.19%
Shares Change (QoQ)	+51.51%
Owned by Insiders (%)	34.55%
Owned by Institutions (%)	10.47%
Float	19.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	191.80
PB Ratio	44.66
P/TBV Ratio	45.52
P/FCF Ratio	11,845.55
P/OCF Ratio	6,451.56
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-170.90
EV / Sales	187.78
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	11,597.38

Financial Position

The company has a current ratio of 32.92, with a Debt / Equity ratio of 0.01.

Current Ratio	32.92
Quick Ratio	32.70
Debt / Equity	0.01
Debt / EBITDA	0.14
Debt / FCF	2.17
Interest Coverage	72.73

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	4.13%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	57.09
Average Volume (20 Days)	4,431,502

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aimed Bio had revenue of KRW 20.71 billion and -22.75 billion in losses. Loss per share was -563.60.

Revenue	20.71B
Gross Profit	20.71B
Operating Income	3.70B
Pretax Income	-22.76B
Net Income	-22.75B
EBITDA	5.10B
EBIT	3.70B
Loss Per Share	-563.60

Balance Sheet

The company has 83.93 billion in cash and 725.96 million in debt, giving a net cash position of 83.20 billion or 1,296.85 per share.

Cash & Cash Equivalents	83.93B
Total Debt	725.96M
Net Cash	83.20B
Net Cash Per Share	1,296.85
Equity (Book Value)	88.92B
Book Value Per Share	1,540.38
Working Capital	82.78B

Cash Flow

In the last 12 months, operating cash flow was 615.55 million and capital expenditures -280.30 million, giving a free cash flow of 335.25 million.

Operating Cash Flow	615.55M
Capital Expenditures	-280.30M
Free Cash Flow	335.25M
FCF Per Share	5.23

Margins

Gross margin is 100.00%, with operating and profit margins of 17.85% and -109.88%.

Gross Margin	100.00%
Operating Margin	17.85%
Pretax Margin	-109.92%
Profit Margin	-109.88%
EBITDA Margin	24.63%
EBIT Margin	17.85%
FCF Margin	1.62%

Dividends & Yields

Aimed Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.19%
Shareholder Yield	-18.19%
Earnings Yield	-0.57%
FCF Yield	0.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Aimed Bio has an Altman Z-Score of 0.58 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.58
Piotroski F-Score	3